期刊文献+

阿奇霉素-米诺环素转换疗法治疗肺炎支原体肺炎的疗效 被引量:22

Efficacy of Azithromycin-Minocycline Switch Therapy on Mycoplasma pneumoniae Pneumonia
原文传递
导出
摘要 目的了解米诺环素对肺炎支原体(MP)的抑制作用,观察阿奇霉素-米诺环素转换疗法治疗肺炎支原体肺炎(MPP)的效果。方法应用体外药敏试验测定米诺环素对MP的最小抑菌浓度(MIC),根据药敏试验结果设计临床观察方案。选择2008年12月-2009年12月在首都医科大学附属北京友谊医院儿科住院MPP患儿60例。随机分为治疗组和对照组,初期均静脉滴注阿奇霉素10 mg.kg-1.d-1,连用3 d,治疗组转换口服米诺环素50 mg,每12 h 1次,持续至发热症状消失24~48 h;对照组序贯口服阿奇霉素10 mg.kg-1.d-1,1次.d-1,静脉及口服共7~10 d为1个疗程,可根据病情需要重复疗程。观察2组患儿在发热时间、住院时间、肺外并发症、临床疗效等方面的差异。结果米诺环素对MP标准株的最小抑菌质量浓度为0.1 mg.L-1,对耐大环内酯药物株的最小抑菌质量浓度为0.025~1.000 mg.L-1;2组患儿性别、年龄、住院前病程有可比性;治疗组患儿的发热时间(P=0.000)、住院时间(P=0.002)均短于对照组,且差异有统计学意义;治疗组并发症发生率较对照组低、有效率高,但差异无统计学意义(P=0.196,0.605)。结论米诺环素对MP有良好的抑制作用;应用阿奇霉素-米诺环素转换疗法治疗8岁以上儿童MPP可缩短发热时间、住院时间。 Objective To investigate the inhibitory activity of minocycline against Mycoplasma pneumonia (MP) and efficacy against MP pneumonia (MPP) of azithromycin - minocycline switch therapy. Methods In vitro drug susceptibility test was performed to determine minimum inhibitory concentration( MIC ) of minocycline to MP. Thereafter,the clinical trial was designed according to the results of drug sus- ceptibility test. Sixty children confirmed to with MPP who presented to Pediatric Department of Beijing Friendship Hospital Affiliated to Caphal Medical University between Dec. 2008 and Dec. 2009 were assigned. They were randomly divided into treatment group and control group ; du- ring the initial stage all patients were treated with intravenous infusions of azithromycin 10 mg·kg^-1·d^-1 once daily for 3 days, then treatment group was converted to take oral minocycline 50 mg,every 12 h,until fever symptoms disappeared for 24 -48 h, while control group remained on azithromycin 10 mg·kg^-1·d^-1by oral,once a day. A total treatment course included intravenous infusion and oral lasting 7 - 10 days. Course of treatment could be repeated according to state of illness. Differences in fever period, hospital stay, pulmonary complications, and clinical efficacy of patients in the 2 groups were observed. Results MIC of minocycline against MP standard strains was 0.1 mg· L-1 ,while against drug - resistant strains was 0.025 - 1. 000 mg · L ^-1. Fever time ( P = 0. 000 ) and hospital stay ( P = 0. 002 ) of treatment group were shorter than those in control group. Treatment group tended to had less complication incidence and higher clinical efficacy than those in control group,while the differences were not significant (P = 0. 196,0. 605 ). Conclusions Minocycline shows good inhibitory effect against MP; azithromycin- minocycline switch therapy can shorten fever time and hospital stay in children with MPP.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2012年第22期1760-1762,共3页 Journal of Applied Clinical Pediatrics
基金 国家自然科学基金(30571973) 北京市科技计划课题(Z101107050210018) 北京友谊医院科研启动基金(2010-8)
关键词 药敏试验 肺炎支原体肺炎 阿奇霉素 米诺环素 转换疗法 耐药 儿童 drug susceptibility test Mycoplasma pneumoniae pneumonia azithromycin minocycline switch therapy drug resistance child
  • 相关文献

参考文献3

二级参考文献29

  • 1庹晓晔,柴家科,徐明达,陈璧,盛志勇.人β-防御素3基因在COS-7细胞中的表达[J].军事医学科学院院刊,2004,28(4):344-346. 被引量:12
  • 2Park JR, Eggert A, Caron H. Neurohlastoma: Biology,prognosis and treatment [ J]. Pediatr Clin North Am,2008,55 ( 1 ) :97 - 120.
  • 3Sehroeder H, Wacher J, Larsson H, et al. Unchanged incidence and increased survival in children with neuroblastoma in Denmark 1981 - 2000 :A population - based study [ J ]. Br J Cancer, 2009, 100 ( 5 ) : 853 - 857.
  • 4Weinstein JL, Katzenstein HM, Cohn SL. Advances in the diagnosis and treatment of neumblastoma [ J ]. Oncologist,2003,8 ( 3 ) :278 - 292.
  • 5Li S,Siegal GP. Small cell tumors of bone[ J]. Adv Anat Pathol,2010, 17(1) :1 -11.
  • 6Sung KW, Lee SH, Yoo KH, et al. Tandem high - dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma [ J ]. Bone Marrow Transplant,2007,40 ( I ) : 37 - 45.
  • 7Pearson AD,Pinkerton CR, Lewis IJ,et al. High - dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: A randomised trial [ J ]. Lancet Oncol, 2008,9 ( 3 ) : 247 - 256.
  • 8Wagner LM, Danks MK. New therapeutic targets for the treatment of high - risk neuroblastoma[ J ]. J Cell Biochem,2009,107 ( 1 ) :46 - 57.
  • 9Canete A, Gerrard M, Rubie H, et al. Poor survival for infants with MYCN- amplified metastatic neuroblastoma despite intensified treatment:The international society of paediatrie oncology european neuro- blastoma experience[ J]. J Clih Oncol,2009,27 (7) : 1014 - 1019.
  • 10Suita S, Tajiri T, Kanek O, et al. Implications of MYCN amplification in patients with stage 4 neuroblastoma who undergo intensive chemothera- PY [ J ]. J Pediatr Surg,2007,42 ( 3 ) :489 - 493.

共引文献12

同被引文献220

引证文献22

二级引证文献219

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部